Journal Information

Statistics

Follow this link to access the full text of the article

Original Article
Icatibant use in Brazilian patients with hereditary angioedema (HAE) type 1 or 2 and HAE with normal C1-INH levels: findings from the Icatibant Outcome Survey Registry Study
Anete S. Grumacha,
Corresponding author
anete.grumach@fmabc.net

Corresponding author.
, Marina T. Henriquesa, Maine L.D. Bardoua, Daniele A. Pontarollia, Jaco Bothab, Mariangela Correac, for the IOS Brazil Study Group
a Clinical Immunology, Faculdade de Medicina, Centro Universitario Saúde ABC, Santo André, SP, Brazil
b Takeda Pharmaceuticals International AG, Zurich, Switzerland
c Takeda Distribuidora Ltda, São Paulo, SP, Brazil
Read
16529
Times
was read the article
1781
Total PDF
14748
Total HTML
Share statistics
Article information
ISSN: 03650596
Original language: English
The statistics are updated each day
Year/Month Html Pdf Total
2024 March 170 81 251
2024 February 191 98 289
2024 January 127 66 193
2023 December 157 76 233
2023 November 209 125 334
2023 October 203 92 295
2023 September 169 116 285
2023 August 174 50 224
2023 July 179 54 233
2023 June 9235 94 9329
2023 May 164 55 219
2023 April 176 39 215
2023 March 206 83 289
2023 February 136 52 188
2023 January 121 54 175
2022 December 200 54 254
2022 November 201 97 298
2022 October 294 141 435
2022 September 199 104 303
2022 August 516 71 587
2022 July 996 91 1087
2022 June 725 88 813
Show all

Follow this link to access the full text of the article

Idiomas
Anais Brasileiros de Dermatologia
en pt
Cookies policy Política de cookies
To improve our services and products, we use "cookies" (own or third parties authorized) to show advertising related to client preferences through the analyses of navigation customer behavior. Continuing navigation will be considered as acceptance of this use. You can change the settings or obtain more information by clicking here. Utilizamos cookies próprios e de terceiros para melhorar nossos serviços e mostrar publicidade relacionada às suas preferências, analisando seus hábitos de navegação. Se continuar a navegar, consideramos que aceita o seu uso. Você pode alterar a configuração ou obter mais informações aqui.